Aerska raised $39 million, bringing its total investment to $60 million, as it becomes a standout in the tech funding landscape of Q1 2026.
PRIVATEMay 11, 2026
Amount Raised
$39 Million
Round Type
Venture
DublinBiotechnologyHealth CareMedicalTherapeutics
Description
Aerska, an Irish company, raised $39 million in February 2026, increasing its total investment to $60 million. The funding is part of a larger $17 billion raised by European start-ups in the first quarter of 2026. This strong performance highlights a shift in investor focus toward AI and deep tech. Aerska's mention in Traxcn’s top ten ‘Soonicorn’ list indicates its potential to achieve unicorn status soon.
Company Information
Company
Aerska
Location
Dublin, Dublin, Ireland
About
Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in London, UK.
Fundz sees it the moment Aerska raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DublinBiotechnologyHealth CareMedicalTherapeutics